Johns Hopkins Fourth Annual Retina Festival 2023

Johns Hopkins Fourth Annual Retina Festival 2023

Format: 5 videos + 23 pdfs, size: 6.28 GB

Course Audience: ophthalmologist

Overview:

Date & Location

Saturday, December 2, 2023, 7:00 AM – 5:00 PM, Johns Hopkins School of Medicine, Turner Auditorium, Baltimore, MD

Target Audience

Specialties – Ophthalmology

Overview

The Fourth Annual Retina Festival is an “all-star” line-up of more than 50 faculty members from around the world participating in a Continuing Medical Education event from the Wilmer Eye Institute of the Johns Hopkins University School of Medicine. The program will provide the latest updates from clinical trials and other evidence in the peer-reviewed medical literature that are relevant to the prevention and management of retinal diseases around the world. Topics include the latest, clinically relevant outcomes from clinical trials on age-related macular degeneration, vitreomacular interface abnormalities, hereditary retinal degenerations, diabetic retinopathy, retinal vein occlusions, and the latest in retinal surgery, including live retina surgery demonstrations. In addition to presentations from world experts, 4 panels of experts throughout the day will highlight discussions on applying clinical trial results to day-to-day clinical practice. The course should be of interest to comprehensive ophthalmologists, retina specialists both expert and in training, as well as vision scientists who want an update on the latest clinically relevant topics in retina.

Objectives

1. Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
2. Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
3. Discuss the role of imaging in the management of vitreomacular interface abnormalities.
4. Review the current and emerging therapeutic approaches for surgical retinal diseases.
5. Summarize the evidence of surgical and medical treatments for intraocular tumors.
6. Determine which patients are appropriate for biologic treatments of posterior uveitis.

 

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Atropine for Myopia in the Pediatric Population (PDF Format)

Big Data- Benefits and Limitations When Guiding Clinical Practice (PDF Format)

Biosimilar Agents for Neovascular and Other Retinal Diseases (PDF Format)

Current Management of Sickle Cell Retinopathy (PDF Format)

Diabetic Macular Ischemia (PDF Format)

Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management (PDF Format)

Faricimab or Aflibercept HD for Neovascular AMD (PDF Format)

Faricimab or Aflibercept HD in Diabetic Macular Edema (PDF Format)

From Airlie House to ETDRS to DRCR Retina Network in 2022- Imaging NPDR for Risk Factors to Develop PDR (PDF Format)

Gene Therapy for Neovascular AMD (PDF Format)

Geographic Atrophy- Primary Outcome Results from Phase 3 Clinical Trials (PDF Format)

Geographic Atrophy- Secondary and Exploratory Outcome Results from Phase 3 Clinical Trials (PDF Format)

Imaging Choroidal Neovascularization (PDF Format)

Imaging Pathologic Myopia (PDF Format)

Intraocular Tumors (Video MP4 Format)

Keynote Speech- Lessons Learned and Moving Forward with International Collaborations in Retina (PDF Format)

Macular Telangiectasis Treatment Advances (PDF Format)

Other Hot Topics in Retina (Video MP4 Format)

Panel- Clinical Relevance of Geographic Atrophy Clinical Trials (PDF Format)

Pathologic Myopia and Central Serous Retinopathy (Video MP4 Format)

Pediatric and Inherited Retinal Diseases (Video MP4 Format)

Prevention of Diabetic Retinopathy Worsening (PDF Format)

Refillable Drug Delivery Devices in Common Retinal Diseases (PDF Format)

Retinal Gene Therapy in 2024 (PDF Format)

Retinal Vascular Diseases (Video MP4 Format)

Retina_PROGRAM (PDF Format)

The “Not So Silent” Epidemic of Pathologic Myopia (PDF Format)

Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations (PDF Format)

 

*Detail:

Saturday, December 2, 2023

Welcome and Conference Goals

7:30AM – 7:35AM

Neil Bressler, MD

Keynote Speech: Lessons Learned and Moving Forward with International Collaborations in Retina

7:35AM – 7:45AM

J. Fernando Arevalo, MD, PhD

Age-related Macular Degeneration – Geographic and Other Atrophy- MODERATOR

7:45AM – 8:45AM

Eleonora Lad, MD, PhD

Age-related Macular Degeneration – Geographic and Other Atrophy- MODERATOR

7:45AM – 8:45AM

James Handa, MD

Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management

7:45AM – 7:55AM

Mandeep Singh, MD, PhD

Geographic Atrophy: Primary Outcome Results from Phase 3 Clinical Trials

7:55AM – 8:05AM

Eleonora Lad, MD, PhD

Geographic Atrophy: Secondary and Exploratory Outcome Results from Phase 3 Clinical Trials

8:05AM – 8:15AM

Peter K Kaiser, MD

Preclinical Perspectives to Improve Treatment for Geographic Atrophy

8:15AM – 8:25AM

James Handa, MD

Panel: Clinical Relevance of Geographic Atrophy Clinical Trials

8:25AM – 8:45AM

James Handa, MD

Panel: Clinical Relevance of Geographic Atrophy Clinical Trials

8:25AM – 8:45AM

Mandeep Singh, MD, PhD

Panel: Clinical Relevance of Geographic Atrophy Clinical Trials

8:25AM – 8:45AM

Eleonora Lad, MD, PhD

Panel: Clinical Relevance of Geographic Atrophy Clinical Trials

8:25AM – 8:45AM

Peter K Kaiser, MD

Panel: Clinical Relevance of Geographic Atrophy Clinical Trials -MODERATOR

8:25AM – 8:45AM

Neil Bressler, MD

Age-related Macular Degeneration – Choroidal Neovascularization – MODERATOR

8:45AM – 10:30AM

J. Fernando Arevalo, MD, PhD

Age-related Macular Degeneration – Choroidal Neovascularization – MODERATOR

8:45AM – 10:30AM

Cindy X Cai, MD

Imaging Choroidal Neovascularization

8:45AM – 8:55AM

Voraporn Chaikitmongkol, MD

Gene Therapy for Neovascular AMD

8:55AM – 9:05AM

Peter A Campochiaro, MD

Biosimilar Agents for Neovascular and Other Retinal Diseases

9:05AM – 9:15AM

Sophie J Bakri, MD

Refillable Drug Delivery Devices in Common Retinal Diseases

9:15AM – 9:25AM

Dante Pieramici, MD

Faricimab or Aflibercept HD for Neovascular AMD

9:25AM – 9:35AM

Judy E Kim, MD

Faculty Commentary and Q&A

9:35AM – 10:00AM

Pathologic Myopia and Central Serous Retinopathy -MODERATOR

10:30AM – 11:15AM

Adam S Wenick, MD, PhD

Pathologic Myopia and Central Serous Retinopathy -MODERATOR

10:30AM – 11:15AM

Kyoko Ohno-Matsui, MD

The “Not So Silent” Epidemic of Pathologic Myopia

10:30AM – 10:40AM

Tien Y Wong, MD, PhD

Imaging Pathologic Myopia

10:40AM – 10:50AM

Kyoko Ohno-Matsui, MD

Recent Insights into Central Serous Retinopathy

10:50AM – 11:00AM

Faculty Commentary and Q&A

11:00AM – 11:15AM

Choroidal Melanoma Management in 2024

11:15AM – 11:25AM

Carol L Shields, MD

Intraocular Tumors -MODERATOR

11:15AM – 12:45PM

Carol L Shields, MD

Intraocular Tumors -MODERATOR

11:15AM – 12:45PM

David H Abramson, MD

Retinoblastoma Management in 2024

11:25AM – 11:35AM

David H Abramson, MD

Faculty Commentary and Q&A

11:35AM – 11:45AM

Pediatric and Inherited Retinal Diseases -MODERATOR

12:45PM – 1:45PM

Joseph Anaya, MD, MBA

Pediatric and Inherited Retinal Diseases -MODERATOR

12:45PM – 1:45PM

Ishrat Ahmed, MD, PhD

Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations

12:45PM – 12:55PM

William F Mieler, MD

Atropine for Myopia in the Pediatric Population

12:55PM – 1:05PM

Michael Repka, MD, MBA

Retinal Gene Therapy in 2024

1:05PM – 1:15PM

Byron L Lam, MD

Managing ROP in 2024

1:15PM – 1:25PM

Yoshihiro Yonekawa, MD

Faculty Commentary and Q&A

1:25PM – 1:45PM

Diabetic Macular Ischemia

1:45PM – 1:55PM

Sobha Sivaprasad, MD

Retinal Vascular Diseases -MODERATOR

1:45PM – 3:00PM

Adrienne Scott, MD

Retinal Vascular Diseases -MODERATOR

1:45PM – 3:00PM

Jennifer I Lim, MD

Macular Telangiectasis Treatment Advances

1:55PM – 2:05PM

Emily Chew, MD

Current Management of Sickle Cell Retinopathy

2:05PM – 2:15PM

Jennifer I Lim, MD

Faculty Commentary and Q&A

2:15PM – 2:30PM

Diabetic Retinopathy – MODERATOR

3:00PM – 3:45PM

Jun Kong, MD, PhD

Diabetic Retinopathy – MODERATOR

3:00PM – 3:45PM

Sophie Cai, MD

Prevention of Diabetic Retinopathy Worsening

3:00PM – 3:10PM

Raj Maturi, MD

From Airlie House to ETDRS to DRCR Retina Network in 2022: Imaging NPDR for Risk Factors to Develop PDR

3:10PM – 3:20PM

Jennifer Sun, MD, MPH

Faricimab or Aflibercept HD in Diabetic Macular Edema

3:20PM – 3:30PM

Christina Y. Weng, MD, MBA

Faculty Commentary and Q&A

3:30PM – 3:45PM

Other Hot Topics in Retina – MODERATOR

3:45PM – 5:30PM

Mira Sachdeva, MD, PhD

Other Hot Topics in Retina – MODERATOR

3:45PM – 5:25PM

Elia Duh, MD

Recent Advances and Challenges with Artificial Intelligence in Retina

3:45PM – 3:55PM

Jun Kong, MD, PhD

Big Data: Benefits and Limitations When Guiding Clinical Practice

3:55PM – 4:05PM

Cindy X Cai, MD

Equity, Diversity, and Inclusiveness in Retina

4:05PM – 4:15PM

Adrienne Scott, MD

Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management

4:15PM – 4:25PM

Mandeep Singh, MD, PhD

Faculty Commentary and Q&A -MODERATOR

4:25PM – 4:55PM

Mira Sachdeva, MD, PhD

Faculty Commentary and Q&A -MODERATOR

4:25PM – 4:55PM

Elia Duh, MD